ClinicalTrialsFinder

Cancer of Endometrium Clinical Trials in Bethesda, Maryland

1 recruitingBethesda, Maryland

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer

Endometrial CancerEndometrial CarcinomaCancer of Endometrium+1 more
National Cancer Institute (NCI)60 enrolled1 locationNCT06253494